assessing high-risk aml
Published 4 years ago • 144 plays • Length 3:51Download video MP4
Download video MP3
Similar videos
-
2:19
identifying high-risk aml
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
3:47
the impact of cytogenetic-risk stratification on aml outcomes
-
2:57
the importance of analyzing cytogenetic risk in patients with aml undergoing haploidentical sct
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml
-
1:10:36
an overview of pediatric all, administration of chemotherapy in all
-
4:07
3 stages of money laundering: understand it for aml compliance
-
8:34
aml/cft process simplified: risk management(part 1)
-
1:02
the impact of sequencing in aml
-
7:28
mbg453 with hypomethylating agents in aml and high-risk mds
-
8:21
quazar aml-001: a new standard for aml maintenance therapy
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
1:51
how can we assess quality of life in aml patients?
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
2:09
advances in the management of fit adults with aml
-
1:16
an insight into the beat aml trial and the value of precision medicine
-
1:23
management of high-risk newly diagnosed mm
-
2:25
analyzing aml: novel therapies in review
-
2:14
addressing the high rate of disease relapse following allosct in patients with aml
-
3:25
identifying & monitoring patients with high-risk clonal hematopoiesis
-
1:14
promising novel agents in aml: menin inhibitors